(19)
(11) EP 4 475 869 A2

(12)

(88) Date of publication A3:
26.10.2023

(43) Date of publication:
18.12.2024 Bulletin 2024/51

(21) Application number: 23753684.2

(22) Date of filing: 10.02.2023
(51) International Patent Classification (IPC): 
A61K 38/16(2006.01)
C07K 14/00(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 2319/70; C07K 16/10; C07K 2317/76; A61K 2039/55; A61K 2039/505
(86) International application number:
PCT/US2023/062350
(87) International publication number:
WO 2023/154841 (17.08.2023 Gazette 2023/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.02.2022 US 202263309147 P

(71) Applicant: The Texas A&M University System
College Station, TX 77840 (US)

(72) Inventors:
  • CHEN, Zhilei
    College Station, TX 77873 (US)
  • CHONIRA, Vikas
    College Station, TX 77843 (US)
  • SIMEON, Rudo
    College Station, TX 77843 (US)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) SARS-COV-2 NEUTRALIZING SYNTHETIC PROTEINS